BRAF mutations are found in approximately 3–5% of non-small cell lung cancer (NSCLC) patients, while BRAFV600E-specific mutations are only present in about 2% of NSCLC [2,64]. This evidence concerns the gene BRAF and non-small cell lung carcinoma.